GHK-Cu adds a matrix remodeling and regenerative signaling dimension that complements the direct tissue repair activities of BPC-157 and TB-500
Proper titration minimizes side effect severity with either medication
Not medically eligible: Fella says a patient denied treatment after medical review can receive a full refund
Injection sites rotate around treatment area with optional topical application directly on wounds
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
J Control Release 2020;325:11120.PubMed 16
